T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Polaris
PII
$3.9B
| $2.68M | ﹤0.01% |
26,978
-806
| -3% | -$83.5K |
|
1527
Tenet Healthcare
THC
$21.5B
| $2.67M | ﹤0.01% |
50,755
-2,820
| -5% | -$196K |
|
1528
Guidewire Software
GWRE
$15.2B
| $2.65M | ﹤0.01% |
37,318
-980
| -3% | -$80.2K |
|
|
HEPS
1529
D-Market Electronic Services & Trading
HEPS
$1.01B
| $2.63M | ﹤0.01% |
4,317,966
-11,841,329
| -73% | -$17.2M |
|
1530
AptarGroup
ATR
$8.43B
| $2.62M | ﹤0.01% |
25,412
+615
| +2% | +$67.1K |
|
1531
Arrow Electronics
ARW
$10.6B
| $2.62M | ﹤0.01% |
23,396
+639
| +3% | +$74.6K |
|
1532
Affiliated Managers Group
AMG
$9.57B
| $2.58M | ﹤0.01% |
22,106
-1,409
| -6% | -$181K |
|
1533
Jabil
JBL
$38.8B
| $2.58M | ﹤0.01% |
50,349
+195
| +0.4% | +$11.3K |
|
1534
Spire
SR
$4.89B
| $2.52M | ﹤0.01% |
33,876
+2,468
| +8% | +$186K |
|
|
TGNA
1535
DELISTED
TEGNA Inc
TGNA
| $2.51M | ﹤0.01% |
119,571
+7,275
| +6% | +$158K |
|
1536
Bank of Montreal
BMO
$129B
| $2.44M | ﹤0.01% |
25,425
+1,836
| +8% | +$195K |
|
1537
Brown-Forman Class A
BF.A
$13B
| $2.44M | ﹤0.01% |
36,000
| – | – |
|
1538
ITT
ITT
$19.4B
| $2.43M | ﹤0.01% |
36,092
-11,126
| -24% | -$793K |
|
1539
Alcoa
AA
$13.1B
| $2.42M | ﹤0.01% |
53,027
-1,440,945
| -96% | -$93.5M |
|
1540
Starwood Property Trust
STWD
$6.05B
| $2.42M | ﹤0.01% |
115,721
-970
| -0.8% | -$22.3K |
|
1541
Morningstar
MORN
$7.41B
| $2.4M | ﹤0.01% |
9,928
-358
| -3% | -$90.2K |
|
1542
News Corp Class B
NWS
$17.8B
| $2.4M | ﹤0.01% |
150,717
-10,883
| -7% | -$203K |
|
1543
Westlake Corp
WLK
$10.2B
| $2.37M | ﹤0.01% |
24,141
-1,139,259
| -98% | -$140M |
|
|
ONTF
1544
DELISTED
ON24
ONTF
| $2.35M | ﹤0.01% |
247,571
-680
| -0.3% | -$8.24K |
|
1545
Encompass Health
EHC
$12.3B
| $2.33M | ﹤0.01% |
52,289
+1,778
| +4% | +$91.2K |
|
1546
KBR
KBR
$4.81B
| $2.33M | ﹤0.01% |
48,141
-3,104
| -6% | -$153K |
|
1547
Valley National Bancorp
VLY
$8.3B
| $2.33M | ﹤0.01% |
223,516
+14,216
| +7% | +$169K |
|
|
ITCI
1548
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.33M | ﹤0.01% |
40,742
+1,040
| +3% | +$59K |
|
|
LHCG
1549
DELISTED
LHC Group LLC
LHCG
| $2.32M | ﹤0.01% |
14,870
-328
| -2% | -$54K |
|
1550
Cabot Corp
CBT
$4.45B
| $2.31M | ﹤0.01% |
36,281
+278
| +0.8% | +$19K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.